Precision Oncology Articles & Analysis: Older
6 articles found
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...
Discover how matched tumor-normal sequencing can help clinical researchers detect the somatic origin of variants with certainty. In the era of precision oncology, it has become increasingly common for patients diagnosed with cancer to undergo tumor sequencing. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to advance personalized cancer ...
The digital pathology software company PathPresenter (Montville, New Jersey) and the precision oncology platform firm 4D Path have entered into a partnership that could improve the diagnostic accuracy of breast tumor profiling. ...
Planning and executing oncology trials can quickly become complex, mainly for the following reasons: Budgets: Phase 2 and 3 oncology trial budgets are nearly double those of non-oncology trials, per patient enrolled. Timelines: Regardless of phase, oncology trials, last 14-18 months longer than ...
Name: Imran Ahmed Job Title: Senior Research Scientist Company: Fresenius Kabi Oncology Ltd., Gurgoan, India Imran Ahmed, Senior Research Scientist, Fresenius Kabi Oncology Ltd Fresenius Kabi Oncology, performing with Precision Fresenius Kabi Oncology Ltd. primarily operates in the field of research and ...